• Skip to primary navigation
  • Skip to main content
  • Skip to footer
NICO CorporationSecondary logo

NICO Corporation

Dedicated to revolutionizing minimally invasive neurosurgery

  • Home
  • Patients
  • Professionals
    • Our Capabilities
    • Our Integrated System
    • Our Surgical Focus
    • Our Impact
    • Published Data
    • Investigator Initiated Study Program
      • IIS Program Overview
      • IIS Areas of Interest (AOIs)
    • Donation Request
    • Global Distribution
    • NICO Technologies for Animal Health
    • Neurosurgeon Education
  • Company
    • Our Mission
    • Our Leadership Team
    • News & Events
    • Careers
  • LinkedIn
  • Twitter
  • YouTube

Test-News

Home » Test-News

Test – Display Posts

Upcoming Events

Press Releases

Media Coverage

  • 2023 – AANS Annual Meeting February 14, 2023
  • 2023 – ACVIM Forum February 14, 2023
  • 2023 – Subcortical Surgery Group Annual Meeting February 14, 2023
  • 2023 – Annual Meeting of the Congress of Neurological Surgeons August 19, 2022
  • 2023 – American Association for Laboratory Animal Science National Meeting August 18, 2022
  • New GBM Study PRESERVE Receives $250,000 Grant from NICO Corporation March 15, 2023
  • NICO Raises $12.5 Million in Oversubscribed Investment Round October 27, 2022
  • Unique Partnership Seeks to Advance Precision Medicine Options for Deadly GBM Brain Tumors October 10, 2022
  • First Adaptive Hemorrhagic Stroke Trial Completes Enrollment October 6, 2022
  • NICO and Elite Medical “Dream Team” Form Oncology Tissue Advisory Board September 8, 2022
  • NICO Announces New Distributor for Australia and New Zealand Markets July 18, 2022
  • NICO Secures New Patent Approvals Supporting Neurosurgical Brain Access Solutions May 15, 2022
  • New Technology Enables Option for Neurosurgeons to Avoid Pinning Patients’ Heads for Brain Surgery March 3, 2022
  • Extensive Patent Estate Protects NICO’s Leadership Position in Minimally Invasive Neurosurgery January 30, 2022
  • Brain and Spinal Tumors Glow with Advanced Light Technology December 2, 2021
  • NICO Launches New Xenon Light Technology Enabling Enhanced Visualization in Minimally Invasive Neurosurgery October 21, 2019
  • Neurosurgery Medical Device Maker, NICO Corporation, Expands Globally with International Training Course During World Stroke Meeting in Spain June 3, 2019
  • New Evidence Shows Brain Recovery after Traumatic & Spontaneous Intracerebral Hemorrhage using NICO Minimally Invasive BrainPath Approach April 23, 2019
  • NICO Completes $12.5 Million Capital Raise Supported by Current Shareholders November 19, 2018
  • NICO Awards First Investigator Initiated Study Grant to Mayo Clinic November 14, 2018
  • Viz.ai and NICO Announce Collaboration to Speed Patient Recruitment in the ENRICH Study November 14, 2018
  • Multi-Center Study Shows Improved, Stable Clinical Outcomes in 96% of Patients with Brain METs October 9, 2018
  • NICO Launches Investigator Initiated Study Program to Increase Scientific Data Supporting Minimally Invasive Neurosurgery August 9, 2018
  • NICO Corp. Adds to Strong Intellectual Property Portfolio of 200+ with New Patent Issued Around Revolutionary BrainPath Technology July 17, 2018
  • Global Healthcare Senior Executive Joins NICO Corp. Board of Directors June 19, 2018
  • Accomplished CEO & Entrepreneur of the Year Joins NICO Corp. Board of Directors June 6, 2018
  • Early Intervention of Hemorrhagic Stroke Trial Reaches 100 Patients May 31, 2018
  • Former Neurosurgery Chairman of Henry Ford Health System, Dr. Mark Rosenblum, Joins NICO Corporation Board of Directors May 29, 2018
  • New Published Evidence for Deadly High-Grade Gliomas Linked to Improved Survival May 22, 2018
  • NICO Continues to Innovate with Smallest Trans-Sulcal Brain Access Tool in the World May 1, 2018
  • NICO Corporation Appoints New Vice President of Sales January 18, 2018
  • Inclusion of NICO BrainPath Approach for Minimal Access Surgery into Pilot ERAS Protocol Supports Possibility for Improved Patient Outcomes October 10, 2017
  • Data on Largest Adult Patient Cohort Shows Diversity, Utility of NICO BrainPath® for Treatment of Tumors, Hemorrhages Located in Deep Subcortical Regions October 9, 2017
  • New Study Reveals Nearly $12,000 per Patient Economic Benefit for Hospitals Using New Technology for Brain Tumor Removal and Stroke Treatment August 28, 2017
  • High Interest in Early Removal of Hemorrhagic Stroke Leads to Doubling Number of Clinical Trial Sites July 27, 2017
  • NICO Announces CE Mark for BrainPath® Non-Disruptive Cranial Access Technology April 3, 2017
  • Top Academic Healthcare Centers Presenting New Surgical Options for Stroke Patients February 22, 2017
  • FDA Grants New Clearance for Brain Surgery Technology January 23, 2017
  • Neurosurgery Device Maker Completes $15 Million Capital Raise to Address Increasing Market Demand of New Technologies for Tumor and Stroke February 23, 2016
  • NICO Announces Hemorrhagic Stroke Trial Lead by Emory University and Grady Memorial January 13, 2016
  • NICO Announces Collaboration with Hitachi Aloka Medical to Create Improved Visualization for Difficult to Reach Brain Tumors September 28, 2015
  • NICO Receives Additional FDA Clearance for Specific BrainPath® Indications for Subcortical Access to Brain Tumors, Cysts and Vascular Disease July 27, 2015
  • NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions May 5, 2015
  • Multi-Center Intracerebral Hemorrhage Pilot Study Yields Statistically Significant Data for Early Intervention February 12, 2015
  • NICO BrainPath® Medical Device for Safely Accessing the Brain Wins Indiana Innovation Award September 3, 2014
  • Spectrum Health uses NICO technology for minimally invasive removal of benign cavernoma July 29, 2019
  • When the Stars Align: Trained Surgeon + New Technology & Early Intervention Save Life of Patient with Hemorrhagic Stroke June 1, 2017
  • New Technology in Treating Hemorrhagic Stroke: Is a New Gold Standard on the Horizon? May 10, 2017
  • Stroke Champ Meets a Champ March 14, 2017
  • Trial on Early Intervention of Hemorrhagic Stroke Advances January 17, 2017
  • “Miracle Patient” Undergoes Revolutionary Surgery September 26, 2016
  • New procedure allows doctors to navigate delicate brain tissue to treat bleeding strokes August 9, 2016
  • Studies: Hemorrhagic Stroke Patients Have Second Chance July 13, 2016
  • Footer

    OUR MISSION is SIMPLE

    We provide proven and patented technologies that integrate imaging and intervention for a safe, minimally disruptive approach to brain surgery. This integration drives efficiencies for the patient, surgeon and healthcare provider.

    Customer Service

     Tel: (317) 660-7118
     Email Us

    Follow NICO Here

    • LinkedIn
    • Twitter
    • YouTube
    Social Media Links

    Search Our Website

    privacy policy   ·    terms of use   ·    patents    ·   labeling

    Copyright © 2023 · Nico Corporation · NICO Myriad and BrainPath are “tools” not “treatments”. Physicians should use their best judgment and clinical experience when deciding how to use the Myriad and BrainPath. The latest information, including contraindications, warnings and precautions can be obtained by consulting product labeling or your local NICO representative.